Content area

|
|

Genomet og diabetes

Forfatter(e)
Kristine Højgaard Allin, Torben Hansen & Oluf Borbye Pedersen Novo Nordisk Fondens Metabolismecenter, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet Ugeskr Læger 2014;176:V06140337
Reference: 
Ugeskr Læger 2014;176:V06140337
Blad nummer: 
Sidetal: 
2176-2179
The genome and diabetes
In terms of their genetic architecture monogenic diabetes and type 2 diabetes represent two extremes. Whereas each subtype of monogenic diabetes is caused by one penetrant, rare mutation in a single gene, the genetic susceptibility to type 2 diabetes can be attributed to many low-penetrant variants across the genome. At present, only 10% of the genetic susceptibility to type 2 diabetes can be explained by the hitherto identified 90 genomic loci. Here we briefly review the genetics of monogenic diabetes and type 2 diabetes and outline future directions of research within this field.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer
af Christian Crüger | 06/11
1 Kommentar
af Anders Christiansen | 05/11
1 Kommentar
af Thamilini Umaramanan | 05/11
2 kommentarer